RecruitingNot ApplicableNCT06826105

Pancrelipase With Nutritional Supplement in Patients at Risk of Malnutrition (EFFORT-ENZO)

Effect of Low Dose Pancrelipase With an Oral Nutritional Supplement to Improve Nutrient Bioavailability in Patients at Increased Risk of Malnutrition


Sponsor

Philipp Schuetz

Enrollment

20 participants

Start Date

Sep 22, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study investigates if pancreatic enzymes in combination with oral nutritional supplement can improve nutrient bioavailability in older people with malnutrition or at risk of malnutrition.


Eligibility

Min Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Placebo and a drug called Zenpep for people with malnutrition. The study is currently recruiting participants at 1 location. People eligible for this study include aged 70 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGZenpep

two capsules (each containing 15000 USP units of lipase) together with nutritional supplements

DRUGPlacebo

two capsules (containing placebo) together with nutritional supplements


Locations(1)

Kantonsspital Aarau

Aarau, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06826105


Related Trials